$425 Million is the total value of Aviva Holdings Ltd.'s 7 reported holdings in Q3 2019. The portfolio turnover from Q2 2019 to Q3 2019 was 20.0% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| MRTX | MIRATI THERAPEUTICS INC | $244,323,000 | -24.4% | 3,135,966 | 0.0% | 57.48% | -14.9% | |
| INSG | INSEEGO CORP | $105,434,000 | +0.2% | 21,965,504 | 0.0% | 24.81% | +12.7% | |
| PAM | New | PAMPA ENERGIA S Aspons adr lvl i | $55,417,000 | – | 3,192,244 | +100.0% | 13.04% | – |
| INSEEGO CORPnote 5.500% 6/1 | $13,991,000 | +0.2% | 13,700,000 | 0.0% | 3.29% | +12.7% | ||
| MDCO | Sell | MEDICINES CO | $5,755,000 | -83.9% | 115,100 | -88.3% | 1.35% | -81.9% |
| SLDB | SOLID BIOSCIENCES INC. | $119,000 | +80.3% | 11,488 | 0.0% | 0.03% | +100.0% |
Other managers
Other managers that, in addition to the filing manager(s), that filed the EDGAR filing(s):
- Braslyn Ltd. #1
- Avid Group Ltd. #2
- Braslyn Ltd. #1
Original filings
The following EDGAR filing(s) were analyzed to create this report:
Signatures
The EDGAR filing(s) were signed by:
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| MIRATI THERAPEUTICS INC | 32 | Q3 2023 | 100.0% |
| INSEEGO CORP | 21 | Q3 2023 | 39.6% |
| INSEEGO CORP | 14 | Q3 2023 | 10.2% |
| PAMPA ENERGIA SA ADR | 12 | Q3 2022 | 26.0% |
| MEDICINES CO | 11 | Q3 2019 | 87.4% |
| ESPERION THERAPEUTICS INC NE | 9 | Q1 2019 | 14.2% |
| TANGO THERAPEUTICS INC. | 9 | Q3 2023 | 0.2% |
| SOLID BIOSCIENCES INC. | 9 | Q2 2020 | 0.1% |
| INSEEGO CORP | 8 | Q1 2020 | 41.4% |
| MACROGENICS INC. | 6 | Q4 2018 | 10.0% |
View Aviva Holdings Ltd.'s complete holdings history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2024-02-14 |
| 13F-HR | 2023-11-14 |
| 13F-HR | 2023-08-14 |
| 13F-HR | 2023-05-15 |
| 13F-HR | 2023-02-14 |
| 13F-HR | 2022-11-14 |
| 13F-HR | 2022-08-15 |
| 13F-HR | 2022-05-16 |
| 13F-HR | 2022-02-14 |
| 13F-HR | 2021-11-15 |
View Aviva Holdings Ltd.'s complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.